<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000370.v2.p1" parentStudy="phs000370.v2.p1" createDate="2014-04-10" modDate="2014-04-11">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators</td><td>Todd Golub</td><td>Broad Institute, Cambridge, MA and Dana Farber Cancer Institute, Boston, MA, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Levi Garraway</td><td>Broad Institute, Cambridge, MA and Dana Farber Cancer Institute, Boston, MA, USA</td></tr>
		<tr><td>Funding Source</td><td>Slim Initiative for Genomic Medicine</td><td>Carlos Slim Health Institute, Mexico City, Mexico</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>The Mutational Landscape of Head and Neck Squamous Cell Carcinoma</StudyNameEntrez>
	<StudyNameReportPage>The Mutational Landscape of Head and Neck Squamous Cell Carcinoma</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
		<StudyType>Tumor vs. Matched-Normal</StudyType>
		<StudyType>Exome Sequencing</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This study was the first-known large-scale effort to uncover the mutational spectrum of head and neck cancers. We analyzed whole-exome sequence from 92 tumor-normal pairs and retained 74 of them for significance analysis. The majority exhibited a mutational profile consistent with tobacco exposure; human papilloma virus sequence was detectable in 15% of cases. In addition to identifying previously known HNSCC genes (<i>TP53, CDKN2A, PTEN, PIK3CA, and HRAS</i>), the analysis revealed many genes not previously implicated in this malignancy. At least 30% of cases harbor mutations in genes (such as <i>NOTCH1, IRF6, TP63</i>) that regulate squamous differentiation, implicating alterations in this process as a major driver of HNSCC carcinogenesis. Altogether, the results suggest that large-scale exome sequencing may illuminate fundamental tumorigenic mechanisms with important therapeutic implications.</p>]]>
	</Description>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Journal authors="Nicolas Stransky, Ann Marie Egloff, Aaron D. Tward, Aleksandar D. Kostic, Kristian Cibulskis, Andrey Sivachenko, Gregory V. Kryukov, Michael Lawrence, Carrie Sougnez, Aaron McKenna, Erica Shefler, Alex H. Ramos, Petar Stojanov, Scott L. Carter, Douglas Voet, Maria L Cort&#233;s, Daniel Auclair, Michael F. Berger, Gordon Saksena, Candace Guiducci, Robert Onofrio, Melissa Parkin, Marjorie Romkes, Joel L. Weissfeld, Raja R. Seethala, Lin Wang, Claudia Rangel-Escare&#241;o, Juan Carlos Fernandez-Lopez, Alfredo Hidalgo-Miranda, Jorge Melendez-Zajgla, Wendy Winckler, Kristin Ardlie, Stacey B. Gabriel, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub, Levi A. Garraway, Jennifer R. Grandis" title="The Mutational Landscape of Head and Neck Squamous Cell Carcinoma" journal="Science, Accepted"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Head and Neck Neoplasms"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators">
			<AttName>Todd Golub</AttName>
			<Institution>Broad Institute, Cambridge, MA and Dana Farber Cancer Institute, Boston, MA, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Levi Garraway</AttName>
			<Institution>Broad Institute, Cambridge, MA and Dana Farber Cancer Institute, Boston, MA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Slim Initiative for Genomic Medicine</AttName>
			<Institution>Carlos Slim Health Institute, Mexico City, Mexico</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-CA-MDS" longName="Disease-Specific (Cancer, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000370.v2.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000370.v2.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000370.v2.p1" FileName="DUC-Genomic_Sequencing_of_Head_and_Neck_Cancer-Updated_6.21.2011.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Cancer, MDS)</ConsentName>
        <ConsentAbbrev>DS-CA-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
